Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to City of Hope, Alnylam, and More


Title: RNA Sequence-specific Mediators of RNA Interference

Patent Number: 8,790,922

Filed: Oct. 4, 2010

Lead Inventor: Thomas Tuschl, Max Planck Institute

Title: Double-stranded and Single-stranded RNA Molecules with 5' Triphosphates and Their Use for Inducing Interferon

Patent Number: 8,791,082

Filed: Sept. 21, 2007

Lead Inventor: John Rossi, City of Hope

Title: Nuclear Reprogramming Factor Comprising miRNA and a Protein Factor

Patent Number: 8,791,248

Filed: Dec. 7, 2011

Lead Inventor: Shinya Yamanaka, Kyoto University

Title: Compositions and Methods for Inhibiting Expression of the HAMP Gene

Patent Number: 8,791,250

Filed: May 23, 2013

Lead Inventor: Tomoko Nakayama, Alnylam Pharmaceuticals

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.